# A Performance Evaluation of the Lumiradx Point of Care HbA1c Device

> **NCT05403853** · NA · COMPLETED · sponsor: **LumiraDx UK Limited** · enrollment: 334 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DIAGNOSTIC_TEST:** Venepuncture
- **DIAGNOSTIC_TEST:** Fingerstick

## Key facts

- **NCT ID:** NCT05403853
- **Lead sponsor:** LumiraDx UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-19
- **Primary completion:** 2022-10-07
- **Final completion:** 2022-10-07
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2024-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05403853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05403853, "A Performance Evaluation of the Lumiradx Point of Care HbA1c Device". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05403853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*